|
|
发表于 11-12-2015 12:05 AM
|
显示全部楼层
Notice of Person Ceasing (29C)Particulars of Substantial Securities HolderName | JUARA SEJATI SDN BHD | Address | Lot 13-01A Level 13 (East Wing)
Berjaya Times Square,
No. 1 Jalan Imbi
Kuala Lumpur
55100 Wilayah Persekutuan
Malaysia. | NRIC/Passport No/Company No. | 185618-M | Nationality/Country of incorporation | Malaysia | Descriptions (Class & nominal value) | Ordinary Shares of RM0.10 each. | Date of cessation | 08 Dec 2015 | Name & address of registered holder | Juara Sejati Sdn BhdLevel 12, Berjaya Times Square,No. 1 Jalan Imbi,55100 Kuala Lumpur |
Currency |
| | No of securities disposed | 10,800,000 | Price Transacted ($$) |
| | Circumstances by reason of which Securities Holder has interest | Cessation of substantial shareholding following the disposal via open market. | Nature of interest | DIRECT |  | Date of notice | 08 Dec 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 14-12-2015 10:44 PM
|
显示全部楼层
本帖最后由 icy97 于 15-12-2015 03:55 PM 编辑
独立顾问： 康盛人生出价合理 新生股东应接受献购
财经新闻 财经 2015-12-15 07:44
（吉隆坡14日讯）独立顾问Mercury证券认为，大股东康盛人生（Cordlife Group Limited）出价每股45仙，强制献购未持有的新生（STEMLFE，0137，创业板）股权的价格公平合理。
该证券也建议股东，接受康盛人生提出的献购，不过，该决定将视乎个人风险和特别投资需求，因此，建议股东们在作出决定前，密切观察新生的股价和献购的相关宣布。
“若新生的股价高于献购价，在考量到相关的交易成本，你或可考虑在公开市场脱售新生股权。”
Mercury证券是根据加总估值法，计算出1亿510万令吉至1亿730万令吉的合理价值，相等于新生每股42仙至43仙的合理价格。
再者，45仙的献购价，相等于5天、1个月、3个月、6个月和1年加权均价的溢价介于10%和21.79%。
该证券指出，新生的股票流通率不足，过去一年直至今年10月的平均每月交投量，仅占股票自由流通量（Free Float）的2.88%。
股票流通率偏低
“考量到该股的流通率不足，目前的献购不失为一个良机，尤其是持有显著数量的新生股，可以更有效和快速的方式发挥该股的投资，转换成现金。”
康盛人生上月以135万令吉，或每股45仙，增持新生的300万股，相等于1.21%股权，将持股率从原有的31.81%，推高至33.03%，触动强制性献购门槛。
随后，康盛人生宣布，将以每股45仙，强制献购未持有的新生股权。
康盛人生是一家新加坡上市公司，主要提供脐带血储存服务及营运脐带血库，业务遍布新加坡、香港、印度、印尼和菲律宾。
而新生则是大马首家及领导型的私人脐带血库业者。
康盛人生没有意图要维持新生的上市地位，因此无需采取任何行动，解决大众持股率不达标的问题。【南洋网财经】
Subject | INDEPENDENT ADVICE CIRCULAR TO SHAREHOLDERS IN RELATION TO THE UNCONDITIONAL TAKE-OVER OFFER BY CORDLIFE GROUP LIMITEED ("OFFEROR") THROUGH MAYBANK INVESTMENT BANK BERHAD TO ACQUIRE ALL THE REMAINING ORDINARY SHARES OF RM0.10 EACH IN STEMLIFE BERHAD NOT ALREADY OWNED BY THE OFFEROR ("OFFER SHARES") FOR A CASH OFFER PRICE OF RM0.45 PER OFFER SHARE |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/4949357
|
|
|
|
|
|
|
|
|
|
|
|
发表于 16-12-2015 12:24 AM
|
显示全部楼层
Name | CORDLIFE GROUP LIMITED | Address | 1 Yishun Industrial Street 1
A'Posh Bizhub, #06-01/09
768160
Singapore. | NRIC/Passport No/Company No. | 200102883E | Nationality/Country of incorporation | Singapore | Descriptions (Class & nominal value) | Ordinary Shares of RM0.10 each. | Name & address of registered holder | CORDLIFE GROUP LIMITED1 Yishun Industrial Street 1A'Posh Bizhub, #06-01/09Singapore 768160 |
Details of changesCurrency: Malaysian Ringgit (MYR) | Type of transaction | Description of Others | Date of change | No of securities
| Price Transacted (RM)
| | Acquired | | 15 Dec 2015 | 36,015,550
| 0.450
|
Circumstances by reason of which change has occurred | Increase in interest in the ordinary shares of RM0.10 each in StemLife Berhad ("StemLife") ("StemLife Shares") arising from valid acceptances pursuant to the take-over offer by Cordlife Group Limited ("Cordlife") to acquire all the remaining StemLife Shares not already owned by Cordlife for a cash consideration of RM0.45 per StemLife Share | Nature of interest | Direct | Direct (units) | 161,984,730 | Direct (%) | 65.448 | Indirect/deemed interest (units) |
| | Indirect/deemed interest (%) |
| | Total no of securities after change | 161,984,730 | Date of notice | 15 Dec 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 17-12-2015 02:38 AM
|
显示全部楼层
Name | CORDLIFE GROUP LIMITED | Address | 1 Yishun Industrial Street 1
A'Posh Bizhub, #06-01/09
768160
Singapore. | NRIC/Passport No/Company No. | 200102883E | Nationality/Country of incorporation | Singapore | Descriptions (Class & nominal value) | Ordinary Shares of RM0.10 each. | Name & address of registered holder | CORDLIFE GROUP LIMITED1 Yishun Industrial Street 1A'Posh Bizhub, #06-01/09Singapore 768160 |
Details of changesCurrency: Malaysian Ringgit (MYR) | Type of transaction | Description of Others | Date of change | No of securities
| Price Transacted (RM)
| | Acquired | | 16 Dec 2015 | 15,942,100
| 0.450
|
Circumstances by reason of which change has occurred | Increase in interest in the ordinary shares of RM0.10 each in StemLife Berhad ("StemLife") ("StemLife Shares") arising from valid acceptances pursuant to the take-over offer by Cordlife Group Limited ("Cordlife") to acquire all the remaining StemLife Shares not already owned by Cordlife for a cash consideration of RM0.45 per StemLife Share | Nature of interest | Direct | Direct (units) | 177,926,830 | Direct (%) | 71.89 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 177,926,830 | Date of notice | 16 Dec 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 13-1-2016 02:53 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | Disposal of subsidiary company, Stemvet Sdn Bhd | StemLife Berhad ("StemLife" or "the Company") wishes to announce that on 12 January 2016, Stemlife Therapeutics Sdn Bhd which is a wholly-owned subsidiary of StemLife, has disposed of 2 fully paid ordinary shares of RM0.10 each representing 100% of the issued and paid-up share capital of Stemvet Sdn Bhd ("Stemvet") for a total cash consideration of RM2.00. (hereinafter referred to as "Disposal")
Stemvet has been dormant since its incorporation on 14 November 2007.
The Disposal will have no material effect on the earnings and net assets of the StemLife for the financial year ending 31 December 2016. The Disposal is not subject to the approval of the shareholders of StemLife.
None of the Directors and substantial shareholders of StemLife, or persons connected with them, have any interest, direct or indirect, in the Disposal.
This announcement is dated 12 January 2016. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 3-2-2016 10:36 PM
|
显示全部楼层
康盛人生收购截止 无法获新生90%股权
财经新闻 财经 2016-02-03 12:48
（吉隆坡2日讯）新生（STEMLFE，0137，创业板）大股东康盛人生（Cordlife Group Limited），在收购截止时，仍无法达到90%接受率的门槛。
根据新生的文告，在今天下午5时献购截止时，康盛人生只取得89.88%的接受率。
无法达到90%的门槛，意味着康盛人生无法强制收购其余股权。
康盛人生是在去年11月12日，宣布以135万令吉，或每股45仙，增持新生的300万股，相等于1.21%股权，将持股率从原有的31.81%，推高至33.03%，触动强制献购门槛。
随后，康盛人生宣布以每股45仙，强制献购本身未持有的新生股权。
康盛人生也表示无意维持新生的上市地位，因此无需采取任何行动，来解决公众持股率不达标的问题。【南洋网财经】
Type | Announcement | Subject | TAKE-OVERS & MERGERS (CHAPTER 11 OF LISTING REQUIREMENTS) | Description | STEMLIFE BERHAD ("STEMLIFE" OR "COMPANY")UNCONDITIONAL TAKE-OVER OFFER BY CORDLIFE GROUP LIMITED ("OFFEROR") THROUGH MAYBANK INVESTMENT BANK BERHAD TO ACQUIRE ALL THE REMAINING ORDINARY SHARES OF RM0.10 EACH IN STEMLIFE NOT ALREADY OWNED BY THE OFFEROR ("OFFER SHARES") FOR A CASH OFFER PRICE OF RM0.45 PER OFFER SHARE ("OFFER") | (Unless otherwise stated, the words and abbreviations used herein shall have the same meaning as defined in the offer document in relation to the Offer dated 3 December 2015 which sets out the details, terms and condition of the Offer together with the Form of Acceptance and Transfer ("Offer Document")).
We refer to the Offer Document and the press notices dated 7 December 2015, 23 December 2015, 8 January 2016, 26 January 2016 and 28 January 2016 in relation to the Offer. The Board of Directors of StemLife wishes to announce that the Company has today received the attached press notice from Maybank Investment Bank Berhad on behalf the Offeror informing that the Offer has closed at 5.00 p.m. (Malaysian time) on 2 February 2016 ("Final Closing Date").
Please refer to the attached press notice for the level of acceptances of the Offer as at 5.00 p.m. (Malaysian time) on the Final Closing Date.
This announcement is dated 2 February 2016. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/4992581
|
|
|
|
|
|
|
|
|
|
|
|
发表于 12-2-2016 01:33 AM
|
显示全部楼层
Change in Financial Year End
Old financial year end | 31 Dec 2015 | New financial year end | 30 Jun 2016 |
| Remarks : | | The Board of Directors of StemLife Berhad ("the Company") has on 11 February 2016 approved the change of financial year end of the Company from 31 December to 30 June to be coterminous with the financial year end of the holding company. Accordingly, the next set of audited financial statements shall be for a period of 18 months, made up from 1 January 2015 to 30 June 2016. Thereafter, the financial year end of the Company shall be on 30 June for subsequent years. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 12-2-2016 01:33 AM
|
显示全部楼层
本帖最后由 icy97 于 14-2-2016 01:24 AM 编辑
新生末季亏损收窄
财经新闻 财经 2016-02-13 12:38
（吉隆坡12日讯）新生（STEMLFE，0137，创业板）截至去年12月杪第4季，净亏124万3000令吉或每股净亏0.5仙，优于前年同季净亏的182万2000令吉。
根据文告，由于脐带组织业务捎来更多贡献，加上呆账拨备走低，因而促使当季亏损收窄。
财政截止日改至6月底
第4季营业额按年跌4.82%，至485万6000令吉，主要归咎于处理脐带血干细胞的营业额下滑，抵消了储藏等收入走高的利好因素。
合计全年，公司净亏65万3000令吉或每股净亏0.26仙，低于前年净亏的193万令吉；营业额则年增7.41%，报1823万9000令吉。
另一方面，为了配合大股东康盛人生（Cordlife Group Limited）的财年截止日期，新生董事部今日批准将公司的财年截止日期，从原本的12月31日，更换至6月30日。
由此，公司接下来的最新财报，将从去年1月1日直至今年6月30日，为期18个月。【南洋网财经】
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2015 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Dec 2015 | 31 Dec 2014 | 31 Dec 2015 | 31 Dec 2014 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 4,856 | 5,102 | 18,239 | 16,980 | | 2 | Profit/(loss) before tax | -1,147 | -1,675 | -697 | -1,594 | | 3 | Profit/(loss) for the period | -1,243 | -1,822 | -653 | -1,930 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,243 | -1,822 | -653 | -1,930 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.50 | -0.74 | -0.26 | -0.78 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1000 | 0.1000
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 12-2-2016 08:13 PM
|
显示全部楼层
新生公眾持股僅10%‧大股東無意維持上市地位
2016-02-12 08:35
（吉隆坡11日訊）新生（STEMLFE，0137，創業板貿服組）表示，雖然提出全購計劃的獻購方持股未達90%強制收購門檻，但獻購方無意維持該公司的上市地位。
根據文告，截至本月5日為止，僅有802名公眾人士持有新生的10.1114%股權，不符合25%公眾持股上市條例。
該公司董事部指出，由於獻購方無意維持該公司上市地位，因此目前並未採取任何行動或建議，以提高公眾持股。
新生大股東――新加坡上市公司康盛人生（Cordlife）建議以每股45仙全面獻購其餘股權，截至上週二（2日），康盛人生僅持有新生的89.88%股權，未到90%強制收購門檻。
盤後，新生也公佈，人力成本樽節奏效，截至2015年12月31日第四季為止，淨虧從182萬2千令吉收窄至124萬3千令吉，全年虧損也收窄至65萬3千令吉，前期為193萬令吉。
第四季營業額下跌4.82%，至485萬6千令吉，全年營業額增加7.41%，至1千823萬9千令吉。（星洲日報／財經）
Type | Announcement | Subject | PUBLIC SHAREHOLDINGS SPREAD | Description | StemLife Berhad (StemLife or the Company)Non-compliance with Public Shareholding Spread pursuant to Rule 8.02(1) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad (Bursa Securities) | We refer to the announcements dated 22 December 2015, 23 December 2015 and 28 January 2016 (“Earlier Announcements”). Unless otherwise stated, all definitions and terms used in this announcement shall have the same meaning as stated in the Earlier Announcements in relation to the Public Shareholdings Spread.
The Company wishes to announce that it is not in compliance with the public shareholding spread requirement pursuant to Rule 8.02(1) of the ACE Market Listing Requirements of Bursa Securities (“Public Spread Requirement”). Based on the Record of Depositors of StemLife as at 5 February 2016, the public shareholding spread of StemLife is 10.1114%, with a total of 802 public shareholders.
The Board of Directors of StemLife at this juncture wishes to announce that:-
1. no step has been taken or is proposed to be taken by StemLife at this juncture to comply with the Public Spread Requirement as it was stated in the Offer Document dated 3 December 2015 that in the event the Offeror receives acceptances under the Offer resulting in the Offeror holding 75% or more of the listed shares of StemLife, the Offeror does not intend to maintain the listing status of StemLife and does not intend to address any shortfall to meet the Public Spread Requirement.
2. no Rectification Plan has been formulated and no endeavours have been taken to formulate such a plan as the Offeror does not intend to address any shortfall to meet the Public Spread Requirement.
This announcement is dated 11 February 2016. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 11-4-2016 07:26 PM
|
显示全部楼层
本帖最后由 icy97 于 12-4-2016 01:43 AM 编辑
澳洲Stemlife与大马StemLife并无关系
By Gho Chee Yuan / theedgemarkets.com | April 11, 2016 : 6:51 PM MYT
http://www.theedgemarkets.com/my/article/澳洲stemlife与大马stemlife并无关系
（吉隆坡11日讯）上市于大马交易所的新生（StemLife Bhd）今日指出，该集团与正在清盘的布里斯本公司Stemlife（澳洲Stemlife）并没有关系。
澳洲广播公司（ABC）上周五（4月9日）报道，存储超过2000个样本的私营脐带血库Stemlife，上个月初已经委任清盘人 BRI Ferrier进行清算活动。
新生今日通过文告澄清，澳洲Stemlife是一家私营公司，且不是该集团旗下公司。
“澳洲Stemlife不是新生的姐妹公司，在财务或任何持股权上都没有关系。”
新生总执行长 Sophian Abdul Rahman在文告中保证，该集团的业务仍是如常运作。
“我们想向所有的股东、客户和公众保证，新生的业务一切如常，公司将继续日常营运和为顾客提供服务。”
新生今日无交易。4月6日收于47.5仙，市值为1亿1756万令吉。
（编译：陈慧珊）
Type | Announcement | Subject | OTHERS | Description | Press Statement: StemLife Berhad Clarified no link with Stemlife Australia | The Board of Directors of StemLife Berhad ("StemLife") wishes to clarify that Stemlife Australia has no relationship with StemLife, and is pleased to attach herewith a press statement dated 11 April 2016 in conjunction with the said clarification.
This announcement is dated 11 April 2016. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5054305
|
|
|
|
|
|
|
|
|
|
|
|
发表于 11-5-2016 01:18 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2016 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Fifteen Months | Fifteen Months | 01 Jan 2016
To | 01 Jan 2015
To | 01 Jan 2015
To | 01 Jan 2014
To | 31 Mar 2016 | 31 Mar 2015 | 31 Mar 2016 | 31 Mar 2015 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 4,155 | 0 | 22,394 | 0 | | 2 | Profit/(loss) before tax | 31 | 0 | -667 | 0 | | 3 | Profit/(loss) for the period | -45 | 0 | -699 | 0 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -45 | 0 | -699 | 0 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.02 | 0.00 | -0.28 | 0.00 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0960 | 0.0994
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 25-8-2016 05:21 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | STEMLIFE BERHAD ("STEMLIFE" OR "THE COMPANY")- INVESTMENT IN CIMB-PRINCIPAL TOTAL RETURN BOND FUND 3 | The Board of Directors of StemLife wishes to announce that the Company had on 24th August 2016 invested RM6 million into the CIMB-Principal Total Return Bond Fund 3 ("the Investment"), a close-ended fund offered by CIMB Asset Management Berhad ("CIMB") for a tenure of three (3) years.
Please refer to the attachment for further details of the announcement.
This announcement is dated 24 August 2016. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5185501
|
|
|
|
|
|
|
|
|
|
|
|
发表于 28-8-2016 05:05 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2016 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Eighteen Months | Eighteen Months | 01 Apr 2016
To | 01 Apr 2016
To | 01 Jan 2015
To | 01 Jan 2015
To | 30 Jun 2016 | 30 Jun 2016 | 30 Jun 2016 | 30 Jun 2016 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 5,121 | 0 | 27,515 | 0 | | 2 | Profit/(loss) before tax | 536 | 0 | -130 | 0 | | 3 | Profit/(loss) for the period | 688 | 0 | -11 | 0 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 688 | 0 | -11 | 0 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.28 | 0.00 | 0.00 | 0.00 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1001 | 0.0994
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-9-2016 04:27 AM
|
显示全部楼层
本帖最后由 icy97 于 22-9-2016 10:42 PM 编辑
新生财报减值项目
外部审计师保留意见
2016年9月22日
（吉隆坡21日讯）新生（STEMLFE，0137，创业板）外部审计师，针对该公司截至今年6月杪的业绩报告，给予“保留意见”（Qualified Opinion）。
该公司向马交所报备，外部审计师安永（Messrs Ernst & Young）表示，针对2013财年（截至12月31日）、2014财年（截至12月31日），以及截至今年6月杪的业绩报告，联号公司泰国新生（Thai Stemlife Co. Ltd）对集团带来的盈亏、减值亏损，以及投资数额，无法获得足够的审计证据。
“我们无法取得联号公司的相关审计纪录，使我们不能直接进行审计工作。”
“同时，由于联号公司以往财政资料的可靠性有限，因此，我们无法评估公司在进行减值后，有关现金流预测的合理程度。”
根据业绩报告，截至2014年1月1日和2014年12月杪，新生在泰国新生的投资数额均为94万5000令吉。
而以投资股权方式计算，在今年6月杪的业绩报告中，截至2014年12月杪的投资为160万5765令吉，以及截至2014年1月1日的投资为148万6588令吉。
而截至今年6月杪，泰国新生净亏损达18万51令吉，2014年则净损21万2962令吉；集团与母公司的资产减值净亏损分别为117万8820令吉，以及94万5000令吉。
除了上述项目之外，安永指，新生截至6月杪的业绩报告的财务状况“正确和公平”。【e南洋】
Type | Announcement | Subject | OTHERS | Description | StemLife Berhad (StemLife or the Company)Qualification in External Auditors Report on the Audited Financial Statements for the financial period ended 30 June 2016 | Pursuant to Rule 9.19(38) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of StemLife wishes to announce that Messrs Ernst & Young, the External Auditors of the Company, had expressed a qualified opinion in their Auditors’ Report on the Audited Financial Statements of the Company for the financial period ended 30 June 2016.
Kindly refer to the attachment for the full text of the qualified opinion.
This announcement is dated 19 September 2016. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5208665
|
|
|
|
|
|
|
|
|
|
|
|
发表于 25-9-2016 04:23 PM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | StemLife Berhad ("StemLife" or "the Company")Clarification on the Article published on The Edge Markets dated 20 September 2016 entitled "Stemlife's accounts lack audit evidence - Independent Auditor" | The Board of Directors of StemLife Berhad ("StemLife") wishes to clarify on the Article published on The Edge Markets dated 20 September 2016. Kindly refer to the attachment for the clarification on the said Article.
This announcement is dated 22 September 2016. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5212013
|
|
|
|
|
|
|
|
|
|
|
|
发表于 28-9-2016 03:45 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | StemLife Berhad ("StemLife" or "the Company")Agreement entered between StemLife and Jerudong Park Medical Centre, Brunei | The Board of Directors of StemLife Berhad (“StemLife”) wishes to announce that the Company had on 1 September 2016 entered into an Agreement with Jerudong Park Medical Centre (“JPMC”) to collaborate with one another on the provision of Stem Cell Banking Services (which comprises collection, testing, processing and preservation of umbilical cord blood stem cells, umbilical cord tissue, Wharton Jelly and peripheral blood stem cells services) to the clients and patients of the Hospital who have entered into the agreement for StemLife Stem cell Banking Services with StemLife which was received on 27 September 2016.
Please refer to the attachment for further details of the announcement.
This announcement is dated 27 September 2016. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5215817
|
|
|
|
|
|
|
|
|
|
|
|
发表于 23-10-2016 05:54 PM
|
显示全部楼层
本帖最后由 icy97 于 24-10-2016 12:23 AM 编辑
大股东维持决定．新生明年2月中前除牌
（吉隆坡20日讯）新生（STEMLFE，0137，创业板贸服组）大股东康盛人生（Cordlife）维持不保留新生上市地位的决定，且预计在明年2月15日之前启动除牌程序。
新生首席执行员苏菲安在股东大会后表示，康盛人生目前在与顾问商讨中，以采取下一步的行动。
“据我所知，康盛人生依然维持决定，即不保持新生的上市地位。”
根据大马交易所资料，该公司的除牌程序获得延长6个月至明年2月15日。
苏菲安补充，基于他的立场，因此不能给予太多关于除牌的意见。
乐观看待明年前景
此外，苏菲安乐观看待新生2017财政年发展前景，认为在注入新产品下，将能推高该公司的营业额和净利。
“目前康盛人生有提供一些服务是我们所没有的，因此，通过康盛人生，我们预计将把新服务带入新生。”
他指出，目前预计是将提供检测服务，包括基因检验和新陈代谢疾病检测服务，不过苏菲安并不愿进一步透露进展详情，仅表示确定将于2017财政年开始提供此新服务。
新生目前提供储存脐带血和脐带组织服务。
苏菲安说，储存脐带组织服务的发展潜能看俏，该公司是于2014年杪提供该项服务。
苏菲安也指出，至于拓展计划，该公司将会针对现有业务为主。
“我们也会考虑地理位置，并通过我们目前拥有的服务，进行拓展计划。”
他说，该公司目前持有新生泰国40%股权，如果在经过评估后拥有发展潜能，则有可能拓展泰国业务。
苏菲安说，民众普遍对于储存脐带血意识不强及经济环境不明朗是该公司目前面对最大的挑战。
针对明日公布的2017财政预算案的期望，苏菲安表示希望政府能够给予更多的企业所得税奖掖。
文章来源：
星洲日报‧财经‧2016.10.21 |
|
|
|
|
|
|
|
|
|
|
|
发表于 9-11-2016 10:43 PM
|
显示全部楼层
本帖最后由 icy97 于 11-11-2016 03:02 AM 编辑
新生首季淨利挫27%
2016年11月09日
http://www.chinapress.com.my/20161109/新生首季淨利挫27/
（吉隆坡9日訊）新生（STEMLFE，0137，創業板貿服）宣佈截至9月底首季財報，淨利按年挫27%至103.9萬令吉，營業額則揚25%至593.2萬令吉。
新生向馬證交所報備文告指，營業額錄得25%增加主要因臍血幹細胞（UCBSC）及臍帶膜（UCL）合約以新收入計算方式入賬、更高的臍帶膜交付及臍帶膠質（wharton’s jelly）存儲服務在今年3月啟業，皆為當季營業額帶來貢獻。
文告指出，儘管業務實際表現較上財年同期更佳，但新生淨利錄得27%滑落，歸因于上財年同期有一筆額外稅務因前一年多付而重新入賬，及當季一筆法律訴訟費用所拖累。
另外，新生通過文告指出，當季銷售及分銷開支按年增加30%至144萬令吉，主要因廣告及促銷支出提高及高昂的雇員成本。
SUMMARY OF KEY FINANCIAL INFORMATION
|
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2016 | 30 Sep 2015 | 30 Sep 2016 | 30 Sep 2015 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 5,932 | 4,748 | 5,932 | 4,748 | | 2 | Profit/(loss) before tax | 1,124 | 1,153 | 1,124 | 1,153 | | 3 | Profit/(loss) for the period | 1,039 | 1,419 | 1,039 | 1,419 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 1,039 | 1,419 | 1,039 | 1,419 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.42 | 0.57 | 0.42 | 0.57 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1043 | 0.1001
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 12-11-2016 03:28 AM
|
显示全部楼层
出价每股54仙
大股东无条件全购新生
2016年11月11日
（吉隆坡10日讯）新生（STEMLFE，0137，创业板）董事部宣布，在11月10日（周四）接获大股东康盛人生（Cordlife）通知，展开无条件全面收购。
截至10日，康盛人生共持有新生2亿2247万2929股，或相等于89.88%股权。
届时，康盛人生将出价每股54仙，收购剩余的2502万7071股或10.12%股权。
根据文告，康盛人生拥有足够资金完成以上收购。
收购将以现金交易，并开放21天。
新生高层将召开董事会议，以针对此事进行讨论。【e南洋】
Type | Announcement | Subject | TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A)) | Description | STEMLIFE BERHAD ("STEMLIFE" OR "THE COMPANY")RECEIPT OF NOTICE OF UNCONDITIONAL TAKE-OVER OFFER FROM CORDLIFE GROUP LIMITED ("CGL" OR "OFFEROR") THROUGH MAYBANK INVESTMENT BANK BERHAD ("MAYBANK IB") | The Board of Directors of StemLife Berhad (“Board”) wishes to announce that the Company has on 10 November 2016 received a notice of unconditional take-over offer (“Notice”) from Maybank IB on behalf of the Offeror to acquire all the remaining ordinary shares of RM0.10 each in StemLife not already owned by the Offeror (“Offer Shares”) at a cash offer price of RM0.54 per Offer Share (“Offer”).
The Board will hold a Board meeting to deliberate the Offer and make an announcement in due course.
A copy of the Notice is attached herewith and will be posted to the holders of the Offer Shares within seven (7) days from the date of this announcement.
This announcement is dated 10 November 2016. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5256317
|
|
|
|
|
|
|
|
|
|
|
|
发表于 17-11-2016 05:27 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | StemLife Berhad (StemLife or the Company)Collaboration Agreement entered between StemLife and Pantai Hospital Kuala Lumpur, a branch of Pantai Medical Centre Sdn Bhd | The Board of Directors of StemLife Berhad (“StemLife”) wishes to announce that the Company had on 1 November 2016 entered into a Collaboration Agreement (“Collaboration Agreement”) with Pantai Hospital Kuala Lumpur to collaborate with one another on the provision of Stem Cell Banking Services (which comprises collection, testing, processing, banking, storage and preservation of umbilical cord blood stem cells, umbilical cord tissue, Wharton Jelly and peripheral blood stem cells services) to the clients and patients of the Pantai Hospital Kuala Lumpur who have entered into the agreement for StemLife Stem cell Banking Services with StemLife which was received on 16 November 2016.
Please refer to the attachment for further details of the announcement.
This announcement is dated 16 November 2016. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5261181
|
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
3015 
48
